Ray Enclave Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-12-2024
- Paid Up Capital ₹ 0.91 M
as on 07-12-2024
- Company Age 28 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.00 Cr
as on 07-12-2024
- Satisfied Charges ₹ 7.50 Cr
as on 07-12-2024
- Revenue 18.14%
(FY 2022)
- Profit 2808.85%
(FY 2022)
- Ebitda 3087.04%
(FY 2022)
- Net Worth 26.23%
(FY 2022)
- Total Assets -5.92%
(FY 2022)
About Ray Enclave
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.91 M.
The company currently has active open charges totaling ₹11.00 Cr. The company has closed loans amounting to ₹7.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sreela Ray and Neelakshi Ray serve as directors at the Company.
- CIN/LLPIN
U70101WB1996PTC076279
- Company No.
076279
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ray Enclave?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sreela Ray | Director | 01-Jan-1996 | Current |
Neelakshi Ray | Director | 01-Jan-1996 | Current |
Financial Performance and Corporate Structure Insights of Ray Enclave.
Ray Enclave Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 18.14% increase. The company also saw a substantial improvement in profitability, with a 2808.85% increase in profit. The company's net worth Soared by an impressive increase of 26.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ray Enclave?
In 2021, Ray Enclave had a promoter holding of 96.91% and a public holding of 3.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Track Four Infotec (I) Private LimitedActive 22 years 9 months
Sreela Ray and Neelakshi Ray are mutual person
- Medicare Spryness (I) Private LimitedActive 23 years 1 month
Sreela Ray and Neelakshi Ray are mutual person
- United Medical Practitioners And Establishments Services Pvt. Ltd.Active 31 years 6 months
Sreela Ray and Neelakshi Ray are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 24 Oct 2013 | ₹11.00 Cr | Open |
State Bank Of India Creation Date: 05 Aug 2003 | ₹7.50 Cr | Satisfied |
How Many Employees Work at Ray Enclave?
Unlock and access historical data on people associated with Ray Enclave, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ray Enclave, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ray Enclave's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.